Artivion

Artivion

Yahoo Finance • yesterday

Artivion (AORT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer - Pat MackinExecutive Vice President, Chief Operating Officer and Chief Financial Officer - L... Full story

Yahoo Finance • 12 days ago

3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial p... Full story

Yahoo Finance • 22 days ago

Next Century Growth Investors exits Bloom Energy, Coherent; adds DigitalOcean in Q2

[Annual report under review] Willie B. Thomas In its Q2 portfolio update, Next Century Growth Investors disclosed nine new positions across three sectors. The industrial additions were Park Aerospace Corp. (PKE [https://seekingalpha.com/... Full story

Yahoo Finance • 25 days ago

Below Expected Sales for AMDS Hurt Artivion (AORT) in Q2

Fred Alger Management, an investment management company, released its "Alger Weatherbie Specialized Growth Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a strong recovery... Full story

Yahoo Finance • 2 months ago

3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive tomorrow. Not... Full story

Yahoo Finance • 2 months ago

1 of Wall Street’s Favorite Stocks with Solid Fundamentals and 2 We Question

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek... Full story

Yahoo Finance • 3 months ago

Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding

On May 13, 2026, Yarger Wealth Strategies, LLC disclosed a new position in Artivion (NYSE:AORT), acquiring 634,223 shares in a trade estimated at $25.02 million based on quarterly average pricing. What happened According to a Securities... Full story

Yahoo Finance • 4 months ago

3 Reasons to Avoid AORT and 1 Stock to Buy Instead

Over the last six months, Artivion’s shares have sunk to $37.03, producing a disappointing 18.2% loss - a stark contrast to the S&P 500’s 3.9% gain. This was partly due to its softer quarterly results and may have investors wondering how t... Full story

Yahoo Finance • 4 months ago

Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage plans. This change raises the revenue that insurance companies receive per patie... Full story

Yahoo Finance • 4 months ago

1 Healthcare Stock on Our Watchlist and 2 We Find Risky

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by... Full story

Yahoo Finance • 5 months ago

Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 6 months ago

Liberty All-Star® Growth Fund, Inc. January 2026 Monthly Update

BOSTON, February 14, 2026--(BUSINESS WIRE)--Below is the January 2026 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, January 2026 Investment Approach... Full story

Yahoo Finance • 6 months ago

AORT Crosses Below Key Moving Average Level

In trading on Tuesday, shares of Artivion Inc (Symbol: AORT) crossed below their 200 day moving average of $26.82, changing hands as low as $24.30 per share. Artivion Inc shares are currently trading off about 9.6% on the day. The chart... Full story

Yahoo Finance • 6 months ago

Artivion (AORT) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Date Thursday, Feb. 12, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Pat MackinChief Operating Officer and Chief Financial Officer — Lance A. Berry Need a quote from a Motley Fool ana... Full story

Yahoo Finance • 8 months ago

Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Idexx Laboratories (IDXX) one of those stocks right now? By taking a look at the stock's year-to-dat... Full story

Yahoo Finance • 9 months ago

Liberty All-Star® Growth Fund, Inc. October 2025 Monthly Update

BOSTON, November 14, 2025--(BUSINESS WIRE)--Below is the October 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, October 2025 Investment Approac... Full story

Yahoo Finance • 10 months ago

Strong Results and Improved Guidance Lifted Artivion (AORT)

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their upward traject... Full story

Yahoo Finance • 12 months ago

Artivion CEO Mackin sells $528k in shares

Artivion (NASDAQ:AORT) President and CEO James P. Mackin sold 12,500 shares of common stock on August 15, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sale comes as the stock trades near its 52-week h... Full story

Yahoo Finance • last year

Artivion price target raised to $45 from $32 at Needham

Needham analyst Mike Matson raised the firm’s price target on Artivion (AORT) to $45 from $32 and keeps a Buy rating on the shares. The company’s constant currency revenue growth improved to 14.6% in Q2 from 3.6% in Q1, driven by strong On... Full story

Yahoo Finance • last year

Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth

Earnings Call Insights: Artivion, Inc. (AORT) Q2 2025 MANAGEMENT VIEW * CEO Pat MacKin reported "strong business momentum continued through the second quarter as we delivered total constant currency revenue growth of over 14% and adjus... Full story